KLSE (MYR): SCOMNET (0001)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.25
Today's Change
0.00 (0.00%)
Day's Change
1.25 - 1.27
Trading Volume
314,200
Market Cap
1,043 Million
NOSH
834 Million
Latest Quarter
30-Sep-2024 [#3]
Announcement Date
26-Nov-2024
Next Quarter
31-Dec-2024
Est. Ann. Date
28-Feb-2025
Est. Ann. Due Date
01-Mar-2025
QoQ | YoY
-34.51% | -25.61%
Revenue | NP to SH
146,535.000 | 29,970.000
RPS | P/RPS
17.57 Cent | 7.12
EPS | P/E | EY
3.59 Cent | 34.79 | 2.87%
DPS | DY | Payout %
2.46 Cent | 1.97% | 68.60%
NAPS | P/NAPS
0.50 | 2.50
QoQ | YoY
-5.95% | 7.75%
NP Margin | ROE
20.45% | 7.18%
F.Y. | Ann. Date
30-Sep-2024 | 26-Nov-2024
Latest Audited Result
31-Dec-2023
Announcement Date
30-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
30-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
138,055.000 | 29,727.000
RPS | P/RPS
16.55 Cent | 7.55
EPS | P/E | EY
3.56 Cent | 35.08 | 2.85%
DPS | DY | Payout %
1.86 Cent | 1.49% | 52.22%
NAPS | P/NAPS
0.44 | 2.86
YoY
-9.93%
NP Margin | ROE
21.53% | 8.15%
F.Y. | Ann. Date
31-Dec-2023 | 28-Feb-2024
Revenue | NP to SH
148,945.333 | 29,286.666
RPS | P/RPS
17.85 Cent | 7.00
EPS | P/E | EY
3.51 Cent | 35.61 | 2.81%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-11.03% | 1.12%
NP Margin | ROE
19.66% | 6.99%
F.Y. | Ann. Date
30-Sep-2024 | 26-Nov-2024
Last 10 FY Result | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 148,945 | 146,535 | 138,055 | 158,328 | 145,441 | 128,411 | 122,969 | 88,288 | 34,447 | 30,413 | 34,941 | 33,528 | 17.01% | |
PBT | 37,921 | 38,476 | 37,901 | 42,867 | 32,378 | 30,453 | 23,613 | 16,092 | 2,033 | 2,332 | 2,972 | 720 | 55.28% | |
Tax | -8,634 | -8,506 | -8,174 | -9,864 | -7,088 | -7,867 | -4,792 | -3,919 | 556 | 14 | 11 | 57 | - | |
NP | 29,286 | 29,970 | 29,727 | 33,003 | 25,290 | 22,586 | 18,821 | 12,173 | 2,589 | 2,346 | 2,983 | 777 | 49.88% | |
- | ||||||||||||||
NP to SH | 29,286 | 29,970 | 29,727 | 33,003 | 25,290 | 22,586 | 18,821 | 12,173 | 2,589 | 2,346 | 2,983 | 777 | 49.88% | |
- | ||||||||||||||
Tax Rate | 22.77% | 22.11% | 21.57% | 23.01% | 21.89% | 25.83% | 20.29% | 24.35% | -27.35% | -0.60% | -0.37% | -7.92% | - | |
Total Cost | 119,658 | 116,565 | 108,328 | 125,325 | 120,151 | 105,825 | 104,148 | 76,115 | 31,858 | 28,067 | 31,958 | 32,751 | 14.20% | |
- | ||||||||||||||
Net Worth | 419,179 | 417,121 | 364,827 | 327,510 | 311,366 | 240,822 | 205,759 | 135,255 | 43,740 | 41,310 | 41,310 | 38,799 | 28.25% |
Equity | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Worth | 419,179 | 417,121 | 364,827 | 327,510 | 311,366 | 240,822 | 205,759 | 135,255 | 43,740 | 41,310 | 41,310 | 38,799 | 28.25% | |
NOSH | 838,358 | 834,242 | 790,127 | 761,975 | 759,431 | 677,038 | 643,000 | 644,074 | 243,000 | 243,000 | 243,000 | 242,500 | 14.01% |
Ratio Analysis | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NP Margin | 19.66% | 20.45% | 21.53% | 20.84% | 17.39% | 17.59% | 15.31% | 13.79% | 7.52% | 7.71% | 8.54% | 2.32% | - | |
ROE | 6.99% | 7.18% | 8.15% | 10.08% | 8.12% | 9.38% | 9.15% | 9.00% | 5.92% | 5.68% | 7.22% | 2.00% | - |
Per Share | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 17.77 | 17.57 | 17.79 | 20.79 | 19.15 | 18.97 | 19.12 | 13.71 | 14.18 | 12.52 | 14.38 | 13.83 | 2.83% | |
EPS | 3.49 | 3.59 | 3.83 | 4.33 | 3.33 | 3.34 | 2.93 | 1.89 | 1.07 | 0.97 | 1.23 | 0.32 | 31.73% | |
DPS | 3.33 | 2.46 | 2.00 | 2.00 | 1.50 | 1.50 | 1.50 | 0.00 | 0.00 | 0.40 | 0.00 | 0.00 | - | |
NAPS | 0.50 | 0.50 | 0.47 | 0.43 | 0.41 | 0.3557 | 0.32 | 0.21 | 0.18 | 0.17 | 0.17 | 0.16 | 12.71% |
Adjusted Per Share Value based on latest NOSH - 838,358 | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 17.85 | 17.57 | 16.55 | 18.98 | 17.43 | 15.39 | 14.74 | 10.58 | 4.13 | 3.65 | 4.19 | 4.02 | 17.01% | |
EPS | 3.51 | 3.59 | 3.56 | 3.96 | 3.03 | 2.71 | 2.26 | 1.46 | 0.31 | 0.28 | 0.36 | 0.09 | 50.43% | |
DPS | 3.35 | 2.46 | 1.86 | 1.83 | 1.37 | 1.22 | 1.16 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | - | |
NAPS | 0.5025 | 0.50 | 0.4373 | 0.3926 | 0.3732 | 0.2887 | 0.2466 | 0.1621 | 0.0524 | 0.0495 | 0.0495 | 0.0465 | 28.25% |
Price Multiplier on Financial Quarter End Date | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 30/09/24 | 30/09/24 | 29/12/23 | 30/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 29/12/17 | 30/12/16 | 31/12/15 | 31/12/14 | - | |
Price | 1.36 | 1.36 | 1.22 | 1.57 | 2.01 | 1.85 | 0.725 | 0.56 | 0.40 | 0.135 | 0.12 | 0.095 | - | |
P/RPS | 7.65 | 7.74 | 6.86 | 7.55 | 10.50 | 9.75 | 3.79 | 4.09 | 2.82 | 1.08 | 0.83 | 0.69 | 29.05% | |
P/EPS | 38.93 | 37.86 | 31.86 | 36.23 | 60.36 | 55.46 | 24.77 | 29.63 | 37.54 | 13.98 | 9.78 | 29.65 | 0.80% | |
EY | 2.57 | 2.64 | 3.14 | 2.76 | 1.66 | 1.80 | 4.04 | 3.38 | 2.66 | 7.15 | 10.23 | 3.37 | -0.78% | |
DY | 2.45 | 1.81 | 1.64 | 1.27 | 0.75 | 0.81 | 2.07 | 0.00 | 0.00 | 2.96 | 0.00 | 0.00 | - | |
P/NAPS | 2.72 | 2.72 | 2.60 | 3.65 | 4.90 | 5.20 | 2.27 | 2.67 | 2.22 | 0.79 | 0.71 | 0.59 | 17.90% |
Price Multiplier on Announcement Date | ||||||||||||||
AQR | T4Q | 31/12/23 | 31/12/22 | 31/12/21 | 31/12/20 | 31/12/19 | 31/12/18 | 31/12/17 | 31/12/16 | 31/12/15 | 31/12/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 26/11/24 | 26/11/24 | 28/02/24 | 21/02/23 | 22/02/22 | 12/03/21 | 27/02/20 | 01/03/19 | 28/02/18 | 28/02/17 | 29/02/16 | 27/02/15 | - | |
Price | 1.22 | 1.22 | 1.29 | 1.37 | 1.52 | 1.79 | 0.74 | 0.75 | 0.40 | 0.135 | 0.105 | 0.13 | - | |
P/RPS | 6.87 | 6.95 | 7.25 | 6.59 | 7.94 | 9.44 | 3.87 | 5.47 | 2.82 | 1.08 | 0.73 | 0.94 | 25.46% | |
P/EPS | 34.92 | 33.96 | 33.68 | 31.62 | 45.64 | 53.66 | 25.28 | 39.68 | 37.54 | 13.98 | 8.55 | 40.57 | -2.04% | |
EY | 2.86 | 2.94 | 2.97 | 3.16 | 2.19 | 1.86 | 3.96 | 2.52 | 2.66 | 7.15 | 11.69 | 2.46 | 2.11% | |
DY | 2.73 | 2.02 | 1.55 | 1.46 | 0.99 | 0.84 | 2.03 | 0.00 | 0.00 | 2.96 | 0.00 | 0.00 | - | |
P/NAPS | 2.44 | 2.44 | 2.74 | 3.19 | 3.71 | 5.03 | 2.31 | 3.57 | 2.22 | 0.79 | 0.62 | 0.81 | 14.49% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Probably as Ambu's order has been recovering since the third quarter of last year
2024-02-26 15:51
Price is rather high (PE 34x) while future upside is not that great..
Mermaid orders would be halted in April this year. Though it’s mentioned to be resumed by Sept when internal dispute is settled, there is uncertainty whether the dispute can be settled by then..
better wait for it the price to be cheaper first then only enter..
2024-03-06 10:07
Be cautious of this company.
Between August 2020 and March 2024,
they have continually added 170,117,400 shares through additional listings, which dilutes shareholder benefits. This trend of adding approximately 3,956,218 shares per month continues.
The management of this listed company is not sincere in fostering business growth;
instead, they manipulate share units for their own benefit.
2024-03-07 19:35
c328 ,
the Company issued FREE warrant of 1:3 to all existing shareholders on 2019, then they are eligible to convert warrant at RM0.65 per share (which the price are similar at the mother share price at 2019). So the convertion is a REWARD to shareholders who hold long term.
2024-03-08 08:14
ha.. lets the market take time to digest all the dilution impact and production line impact first.
2024-03-08 23:36
Analysis of Scomnet from TA research. Quite good
https://www.thestar.com.my/business/business-news/2024/03/06/medical-segment-to-drive-supercomnet-earnings
2024-03-12 09:44
Management sold too fast 😆
https://klse.i3investor.com/web/insider/detail/D_178307_150721058
2024-04-29 14:56
omg today volume huge.
now only two distinct directions :-
1) Fly uppp and away
2) Crash and hard landing
You have to bet which direction it goes..
2024-04-29 16:04
Nice, epf started tapping in 🤗
https://klse.i3investor.com/web/insider/detail/SBSH_584740_174085760
2024-05-06 10:17
nope. it's normal, when have Exercise of Warrants - 2,224,166 shares at 0.650. Just wait.
2024-05-08 10:58
Watch out for results announcement today or tomorrow. More excitment ahead
2024-05-20 15:57
Q1 result was out. Net profit improved QoQ and YoY due to increased in sales of medical products with better profit margin
2024-05-21 10:10
nice, EPF chipped in again
https://klse.i3investor.com/web/insider/detail/SBSH_586680_3225427302
2024-05-29 11:00
Europe stocks extend losses after worst session for a month; Royal Mail owner IDS up 4% on sale agreement
Jenni Reid
2024-05-29 23:01
Scomnet is expected to rake in net profit of RM39.15 million this year, according to Bloomberg, compared to RM29.73 million in the previous year.
2024-06-04 17:26
Supercomnet looks for another shot in the arm in medical segment
https://theedgemalaysia.com/node/719123
2024-07-23 20:20
Commendable Q2 results but share price doesn't react ...
https://www.dagangnews.com/article/jualan-segmen-perubatan-supercomnet-pada-separuh-kedua-2024-diunjur-meningkat-kata-ta-securities-40338
2024-08-28 19:28
Scomnet
Revenue RM37.28 million, up 14.6% (YoY)
Net profit RM5.51 million, down 25.6% (YoY)
Disappointing QR! Be prepared for bloodbath!
1 week ago
james bond dont spread negativity if you nor sure the bright prospect about this company.
6 days ago
Michael Kwok
Post removed.Why?
2024-02-15 15:58